An Exploratory Dose-Escalating Study Investigating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Intravenous Atacicept in Patients with Systemic Lupus Erythematosus

Atacicept, a recombinant fusion protein containing the extracellular, ligand-binding portion of the transmembrane activator and calcium modulator and cyclophilin-ligand interactor receptor, and the Fc portion of human immunoglobulin (Ig) G, is designed to block the activity of B-lymphocyte stimulato...

Descripción completa

Detalles Bibliográficos
Autores principales: Pena-Rossi, C, Nasonov, E, Stanislav, M, Yakusevich, V, Ershova, O, Lomareva, N, Saunders, H, Hill, J, Nestorov, I
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2009
Materias:
Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3835146/
https://www.ncbi.nlm.nih.gov/pubmed/19395457
http://dx.doi.org/10.1177/0961203309102803

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3835146/
https://www.ncbi.nlm.nih.gov/pubmed/19395457
http://dx.doi.org/10.1177/0961203309102803

Ejemplares similares